Guangzhou Kingmed Diagnostics Group Dividends and Buybacks
Dividend criteria checks 3/6
Guangzhou Kingmed Diagnostics Group is a dividend paying company with a current yield of 2.99%.
Key information
3.0%
Dividend yield
0.7%
Buyback Yield
Total Shareholder Yield | 3.6% |
Future Dividend Yield | 2.8% |
Dividend Growth | 36.2% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.880 |
Payout ratio | 255% |
Recent dividend and buyback updates
Recent updates
Guangzhou Kingmed Diagnostics Group (SHSE:603882) Has A Pretty Healthy Balance Sheet
Dec 13Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 06Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)
Sep 27Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next
Sep 03Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?
Aug 25A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)
Jun 04Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings
May 02Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%
Apr 17Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking
Feb 28Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 603882 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 603882's dividend payments have increased, but the company has only paid a dividend for 6 years.
Dividend Yield vs Market
Guangzhou Kingmed Diagnostics Group Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (603882) | 3.0% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.1% |
Industry Average (Healthcare) | 1.8% |
Analyst forecast (603882) (up to 3 years) | 2.8% |
Notable Dividend: 603882's dividend (2.99%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 603882's dividend (2.99%) is in the top 25% of dividend payers in the CN market (2.15%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (254.9%), 603882's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (76.8%), 603882's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 20:47 |
End of Day Share Price | 2024/12/26 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangzhou Kingmed Diagnostics Group Co., Ltd. is covered by 20 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Hao Wu | Chasing Securities |
Pei Cheng | China Galaxy Securities Co., Ltd. |
Jin Zhang | China International Capital Corporation Limited |